Country for PR: United States
Contributor: PR Newswire New York
Tuesday, May 14 2019 - 08:00
AsiaNet
Brain imaging AI leader icometrix raises $18 million in new funding
LEUVEN, Belgium and GENEVA and BOSTON, May 14, 2019 /PRNewswire-AsiaNet/ --

-- Company's technology will transform care for patients with brain disorders 
and injuries

icometrix, the global expert in brain imaging Artificial Intelligence 
solutions, has raised $18 million through a partnership led by Forestay Capital 
alongside Optum Ventures and existing investor Capricorn Venture Partners.

icometrix's icobrain software, which is both CE-marked and FDA-cleared, 
extracts clinically meaningful information from brain MRI and CT scans of 
patients with neurological disorders, such as Multiple Sclerosis, Alzheimer's 
disease and dementia, and traumatic brain injury. The icobrain AI solutions are 
already used in more than 100 hospitals and imaging center networks worldwide, 
and in clinical studies by 4 out of the Top 5 pharmaceutical companies.

"With icobrain, medical images can be read faster, more consistently and in a 
more personalized fashion by quantifying the volume of brain structures and 
abnormalities," said Wim Van Hecke, CEO of icometrix. "One in three people will 
suffer from a brain disorder, often due to a chronic disease, leading to an 
immense burden for patients, friends, families, caregivers and society. Brain 
scans play a central role in patient diagnosis and monitoring, creating a huge 
need for objective and patient-specific evaluation of MRI and CT brain scan 
images with tools like icobrain." 

"Forestay is delighted to partner with icometrix's management and to help drive 
forward its growing success story. This technology transforms the way we 
diagnose, monitor and treat people with brain disorders and we can see its 
immense potential to improve neurological diagnostics, making a complex process 
quicker and more effective for each individual patient. Our own investor, the 
Waypoint Capital group, has a deep heritage in the health care sector and also 
owns Affidea, the largest imaging center network in Europe, which has partnered 
with icometrix to develop the standardization protocols for its large-scale 
deployment across Europe. This gives us great confidence in its future value 
potential," said Frederic Wohlwend, Managing Partner of Forestay Capital.

"We strongly believe in the power of data to help diagnose, monitor and treat 
neurological disorders," said Heather Roxborough, Partner at Optum Ventures. 
"By putting icometrix's innovative AI brain imaging solutions in the hands of 
clinicians and radiologists worldwide, we can help improve the lives of 
millions of people with brain disorders." 

Media contact:
Wim Van Hecke
CEO icometrix
wim.vanhecke@icometrix.com
+32-16-369-000

Press Kit:
https://s3-eu-west-1.amazonaws.com/icometrix-files/Press-releases/Press-Kit-icometrix-20190514.zip


SOURCE: icometrix
Translations

Japanese